Ramm Pharma Corp Stock Net Income
In respect to fundamental indicators, the technical analysis model allows you to check helpful technical drivers of RAMM Pharma, as well as the relationship between them.
RAMM Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing RAMM Pharma's valuation are provided below:RAMM Pharma Corp does not today have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. RAMM |
Search Suggestions
| R | Ryder System | Company |
| RF-PC | Regions Financial | Company |
| RCS | Pimco Strategic Income | Fund |
| RB | ProShares Trust | ETF |
| RCI | Dow Jones Composite | Index |
| RSR | RSR | Cryptocurrency |
| R9900CAT3 | YARNO 7378 14 NOV 32 | Corporate Bond |
| RBUSD | Gasoline RBOB | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, RAMM Pharma Corp reported net income of (7.11 Million). This is 102.08% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 101.24% higher than that of the company.
RAMM Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RAMM Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RAMM Pharma could also be used in its relative valuation, which is a method of valuing RAMM Pharma by comparing valuation metrics of similar companies.RAMM Pharma is currently under evaluation in net income category among its peers.
RAMM Fundamentals
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0789 | |||
| Profit Margin | (1.76) % | |||
| Operating Margin | (1.89) % | |||
| Current Valuation | 1.85 M | |||
| Shares Outstanding | 122.4 M | |||
| Shares Owned By Insiders | 34.88 % | |||
| Shares Owned By Institutions | 0.89 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 4.04 X | |||
| Revenue | 4.12 M | |||
| Gross Profit | (37.32 K) | |||
| EBITDA | (6.36 M) | |||
| Net Income | (7.11 M) | |||
| Cash And Equivalents | 12.79 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 8.69 K | |||
| Current Ratio | 9.18 X | |||
| Book Value Per Share | 0.41 X | |||
| Cash Flow From Operations | (3.82 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | -0.75 | |||
| Market Capitalization | 15.16 M | |||
| Total Asset | 59.71 M | |||
| Net Asset | 59.71 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |